.Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A01A_StomatologicalPreparations.A01AB17_Metronidazole.Metronidazole .Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A01A_StomatologicalPreparations.A01AB17_Metronidazole.Metronidazole| name: | Metronidazole |
| ATC code: | A01AB17 | route: | oral |
| n-compartments | 1 |
Metronidazole is a nitroimidazole antibiotic and antiprotozoal medication used to treat various infections caused by anaerobic bacteria and protozoa, including bacterial vaginosis, trichomoniasis, giardiasis, amebiasis, and certain intra-abdominal and dental infections. It is widely approved and used in clinical practice today.
Pharmacokinetic parameters reported for healthy adult volunteers following oral administration.
Sullins, AK, & Abdel-Rahman, SM (2013). Pharmacokinetics of antibacterial agents in the CSF of children and adolescents. Paediatric drugs 15(2) 93–117. DOI:10.1007/s40272-013-0017-5 PUBMED:https://pubmed.ncbi.nlm.nih.gov/23529866
Vande Griend, JP, et al., & Linnebur, SA (2012). A year in review: new drugs for older adults in 2011. The American journal of geriatric pharmacotherapy 10(4) 258–263. DOI:10.1016/j.amjopharm.2012.05.003 PUBMED:https://pubmed.ncbi.nlm.nih.gov/22682643
Carlson, TJ, et al., & Garey, KW (2022). Fulminant Clostridioides difficile Infection: A Review of Treatment Options for a Life-Threatening Infection. Seminars in respiratory and critical care medicine 43(1) 28–38. DOI:10.1055/s-0041-1740973 PUBMED:https://pubmed.ncbi.nlm.nih.gov/35172356